Pozen (Nasdaq: POZN) cut its losses by 4 cents a share in the third quarter, the company said Thursday before the markets opened.
Pozen said it lost $4.7 million, or 16 cents a share compared to $5.8 million, or 20 cents, in 2004.
The quarterly results did not include a $20 million milestone payment received by Pozen from GlaxoSmithKline in October.
For details, see: biz.yahoo.com/bw/051027/275119.html?.v=1
